Facts and Figures: An overview

2017 was a successful year. SFS Group generated dynamic sales growth and im-proved its position in the medical device industry and in the Americas, thanks to the integration of Tegra Medical. Operating profit showed double-digit growth.

Driven by strong organic growth of 7.4% and the first-time consolidation of Tegra Medical, SFS Group increased its sales in the 2017 financial year by 13.7% to CHF 1,632.7 million. All segments contributed to this pleasing development. Changes in the scope of consolidation had a positive impact of 5.8% and currency movements added 0.5% to reported sales.

Please find detailed information in the media release published on 9 March 2018.

Development of sales by segment

Gross sales
in CHF million
2017
1st half
2017
2nd half
2017 2016 ±PY
Engineered Components 428.2 497.6 925.8 768.1 20.5%
Fastening Systems 190.2 193.8 384.0 355.6 8.0%
Distribution & Logistics 160.2 162.7 322.9 312.8 3.2%
Gross sales 778.6 854.1 1,632.7 1,436.5 13.7%

Download business year 2017

Download business year 2016

Download business year 2015

Download business year 2014

Download business year 2013

Corporate Communications

SFS Group AG
Claude Stadler
Rosenbergsaustrasse 8
CH-9435 Heerbrugg
T +41 71 727 51 51